Nephrodite, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersAtlanta, GA
SAM.gov UEIZ6U2W1BJNMH3
Brands
This company sells these brands.
Nephrodite develops an implantable dialysis platform called Holly™ that continuously filters blood for patients with end-stage kidney disease. The device uses hemofiltration to provide continuous dialysis treatment outside of traditional dialysis centers. Holly™ is currently investigational and not yet approved for commercial use.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Nephrodite, INC. | Atlanta | GA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.




